Finance

Lists
Why is MCRB down 4,35%?
Dive Deeper
MCRB:NASDAQ
Seres Therapeutics Inc
2,42 $
-4,35%
(-0,11) 1D
2,42 $
+0,13% (+0,0031)
After hours
Closed: 14 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MCRB...
Open
2,65 $
High
2,66 $
Low
2,38 $
Mkt. cap
24,06 մլն
Avg. vol.
71,55 հզր
Volume
2,00
52-wk high
29,98 $
52-wk low
2,38 $
EPS
-2,33 $
Beta
0,31
Shares outstanding
9,94 մլն
No. of employees
66
Open
2,65 $
High
2,66 $
Low
2,38 $
Mkt. cap
24,06 մլն
Avg. vol.
71,55 հզր
Volume
2,00
52-wk high
29,98 $
52-wk low
2,38 $
EPS
-2,33 $
Beta
0,31
Shares outstanding
9,94 մլն
No. of employees
66
News stories
From web sources and news partners
About Seres Therapeutics Inc
CEOEric Shaff
Employees66
Founded2010
Headquarters-
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to MCRB in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MCRB in the last 3 months.
Highest
Current 2,42 $
22,00 $ (+809,09%)
Average
17,00 $ (+602,48%)
Lowest
12,00 $ (+395,87%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Newman
Canaccord Genuity
Buy
Maintained
22,00 $
+809,1%
08/06/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
12,00 $
+395,9%
08/05/2026
Edward Tenthoff
Piper Sandler
Hold
Maintained
20,00 $
+726,4%
02/13/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
11/05/2025
Last report
05 օգս, 2026 թ.
Fiscal period
Q2 2026
1,07 $ / -2,18 $
+148,77%beat
Revenue / Est. (USD)
736,00 հզր / 358,00 հզր
+105,59%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
351,00 հզր
438,00 հզր
358,00 հզր
736,00 հզր
Cost of goods sold
13,35 մլն
12,28 մլն
13,20 մլն
9,14 մլն
Cost of revenue
13,35 մլն
12,28 մլն
13,20 մլն
9,14 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,48 մլն
7,54 մլն
8,07 մլն
7,06 մլն
Operating expense
9,48 մլն
7,54 մլն
8,07 մլն
7,06 մլն
Total operating expenses
22,83 մլն
19,82 մլն
21,26 մլն
16,20 մլն
Operating income
-22,48 մլն
-19,38 մլն
-20,91 մլն
-15,47 մլն
Other non operating income
2,84 մլն
2,33 մլն
669,00 հզր
673,00 հզր
EBT including unusual items
8,20 մլն
-15,34 մլն
-19,91 մլն
4,58 մլն
EBT excluding unusual items
-19,02 մլն
-16,60 մլն
-19,91 մլն
-14,61 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
8,20 մլն
-15,34 մլն
-19,91 մլն
4,58 մլն
Net profit margin
2 337,32%
-3 501,14%
-5 562,29%
622,42%
Earnings per share
0,94
-1,76
-2,08
1,07
Interest and investment income
618,00 հզր
445,00 հզր
325,00 հզր
181,00 հզր
Interest expense
-
-
-
-
Net interest expenses
618,00 հզր
445,00 հզր
325,00 հզր
181,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,43 մլն
-18,42 մլն
-20,13 մլն
-14,80 մլն
Gain or loss from assets sale
-
-192,00 հզր
-
139,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps